Cargando…

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue

Polycystic ovary syndrome (PCOS) affects 10% of women and is a lifelong metabolic disorder, with increased risk of type 2 diabetes, fatty liver and cardiovascular disease. Androgen excess is an important driver of metabolic risk. Excess androgen activation in adipose tissue from PCOS women, through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiffer, Lina, Sinclair, Alexandra, Ludwig, Christian, O'Reilly, Michael, Westgate, Connar, Singhal, Rishi, Taylor, Angela, Dunn, Warwick, Arlt, Wiebke, Storbeck, Karl-Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550723/ http://dx.doi.org/10.1210/js.2019-MON-203

Ejemplares similares

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

Intracrine androgen biosynthesis, metabolism and action revisited
por: Schiffer, Lina, et al.
Publicado: (2018)

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2017)

MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
por: Schiffer, Lina, et al.
Publicado: (2017)

MON-193 Androgen Insensitivity Syndrome: A Tale of Two Tails
por: Lizama, Sergio, et al.
Publicado: (2019)

MON-218 Inflammatory Role of Sex Steroids in Hidradenitis Suppurativa: An Androgenic Phenotype
por: Jaleel, Tarannum, et al.
Publicado: (2019)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens
por: Schiffer, Lina, et al.
Publicado: (2021)

MON-035 Does Androgen Exposure Result in Germline Transmission of PCOS-Like Phenotypes and Can It Be Reversed?
por: Lu, Haojiang, et al.
Publicado: (2020)

MON-217 Maternal Androgen Excess and Obesity Induce Cardiac Hypertrophy and Left Ventricular Dysfunction in Female Offspring
por: Manti, Maria, et al.
Publicado: (2019)

MON-033 Androgen Increases the Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS
por: Azhary, Jerilee Mariam Khong, et al.
Publicado: (2020)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

Androgens, Endometriosis and Pain
por: Evans, Susan F., et al.
Publicado: (2021)

MON-201 ER Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS
por: Azhary, Jerilee, et al.
Publicado: (2019)

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics
por: O’Reilly, Michael W., et al.
Publicado: (2019)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

OR25-1 Conditional Deletion of Gonadotropic Androgen Receptor Prevents Elevated Androgen Induced Reproductive Dysfunction in Female Mice
por: Wu, Sheng, et al.
Publicado: (2019)

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
por: Elhassan, Yasir S, et al.
Publicado: (2018)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

SAT-213 Late Diagnosis of Complete Androgen Insensitivity
por: Tsai, Karen, et al.
Publicado: (2019)

Complete Androgen Insensitivity and Decreased Bone Mineral Density
por: Bauer, Elizabeth M, et al.
Publicado: (2021)

MON-219 In Silico and in Vitro Studies of Human 5α-Reductase Type II Variants in Search for Activating Variants Explaining Androgen Excess Reveal New Loss-Of-Function Variants
por: Katharopoulos, Efstathios, et al.
Publicado: (2019)

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
por: Snaterse, Gido, et al.
Publicado: (2021)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

SUN-194 Erasing the Methyl Mark: Mechanism of Androgen Action in the Ovary
por: Roy, Sambit, et al.
Publicado: (2019)

SUN-LB4 Androgenic Profiles of Patients With Severe Insulin Resistance
por: Jha, Smita, et al.
Publicado: (2020)

LBMON231 Virilization Secondary To Androgen Producing Ovarian Serous Cystadenoma
por: De Guzman, Vernon Joseph, et al.
Publicado: (2022)

OR06-2 Paxillin and Androgen Receptor Interact to Modulate Female Fertility
por: Astapova, Olga, et al.
Publicado: (2022)

FRI445 A Late Diagnosis Of Complete Androgen Insensitivity Syndrome
por: Muuse, Janelle, et al.
Publicado: (2023)

ODP404 Effects of Empagliflozin on Serum Androgens Levels in Men Without Diabetes
por: Kosinski, Christophe, et al.
Publicado: (2022)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

SUN-038 Social and Psychological Aspects of Partial Androgen Insensitivity Syndrome, Therapeutic Challenges
por: Masood, Faryal T, et al.
Publicado: (2020)

RF10 | PMON221 11-Oxygenated-Androgens in Females with Severe Insulin Resistance
por: Merke, Deborah, et al.
Publicado: (2022)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

SAT384 Is This A Case of Androgen-Secreting Endometrial Cancer in A Postmenopausal Woman?
por: Taqi, Vian, et al.
Publicado: (2023)

Androgen receptor regulates SRC expression through microRNA-203
por: Siu, Man Kit, et al.
Publicado: (2016)

MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])
por: Liang, Bernice, et al.
Publicado: (2019)

SUN-230 Association of Estrogens and Androgens with Sexual Function after Hematopoietic Stem Cell Transplant
por: Anderson, Lindsey, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0fdvtsvnhi3cdi751pffahphpi